QuickView for oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
2. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
3. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
4. Expression profiles of DGAT1 and DGAT2 double KO and wildtype adipocytes
5. L1000 CMAP - Adipocyte ASC cells treated with small molecule perturbagens

There were no matches for oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor

There were no clinical trials for oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor